Charles B. Bernick
Expertise in
12
conditions

Dr. Charles B. Bernick

Neurology
888 W Bonneville Ave, 
Las Vegas, NV 
Offers Telehealth
Expertise in
12
conditions
888 W Bonneville Ave, 
Las Vegas, NV 

Overview

Charles Bernick is a Neurologist practicing medicine in Las Vegas, Nevada.

Dr. Bernick is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Memory Loss, and Lewy Body Dementia (LBD).

Dr. Bernick is board certified in American Board Of Psychiatry And Neurology and American Board Of Psychiatry And Neurology, 1987. He is actively involved in clinical research, co-authoring 98 peer reviewed articles and participating in 11 clinical trials.

Specialties

Neurology

Licenses

Psychiatry & Neurology in WA

Board Certifications

American Board Of Psychiatry And Neurology
American Board Of Psychiatry And Neurology, 1987

Hospital Affiliations

Henderson Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
SelectHealth
  • HMO
  • POS
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 23 Less Insurance Carriers -

Locations

Cleveland Clinic Nevada
888 W Bonneville Ave, Las Vegas, NV 89106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Enrollment Status: Completed
Publish Date: August 21, 2026
Intervention Type: Drug
Study Drug: Solanezumab
Study Phase: Phase 3
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: March 19, 2026
Intervention Type: Drug
Study Drug: LY3002813
Study Phase: Phase 2
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Enrollment Status: Completed
Publish Date: March 11, 2026
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Study Evaluating the Safety and Efficacy of Simufilam 100 mg Tablets in Subjects With Mild-to-Moderate Alzheimer's Disease
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Study Evaluating the Safety and Efficacy of Simufilam 100 mg Tablets in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: Simufilam
Study Phase: Phase 3
A Double-Blind, Placebo-Controlled 16-Week Study of the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies (DLB)
A Double-Blind, Placebo-Controlled 16-Week Study of the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies (DLB)
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Drug: Neflamapimod
Study Phase: Phase 2
A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: June 12, 2023
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 23, 2023
Intervention Type: Drug
Study Drug: COR388
Study Phase: Phase 2/Phase 3
Therapeutic Effects of Exercise in Adults With Amnestic Mild Cognitive Impairment (MCI)
Therapeutic Effects of Exercise in Adults With Amnestic Mild Cognitive Impairment (MCI)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
Prazosin for Disruptive Agitation in Alzheimer's Disease (AD) (PEACE-AD)
Prazosin for Disruptive Agitation in Alzheimer's Disease (AD) (PEACE-AD)
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drug: Prazosin
Study Phase: Phase 2
View 9 Less Clinical Trials

98 Total Publications

Centrally Acting Medications, Chronic Pain, and Orthopedic Surgical History Among Former American Football Players.
Centrally Acting Medications, Chronic Pain, and Orthopedic Surgical History Among Former American Football Players.
Journal: Neurology
Published: August 28, 2026
Similar Doctors
Expertise in
36
conditions
Expertise in
36
conditions
Referral required
Before you request

Cleveland Clinic Nevada

888 W Bonneville Ave, 
Las Vegas, NV 
 (0.1 miles away)
702-483-6000
Languages Spoken:
English, Hungarian
See accepted insurances
Accepting New Patients
Offers Telehealth

Zoltan Mari is a Neurologist practicing medicine in Las Vegas, Nevada. Dr. Mari is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Focal Dystonia, and Deep Brain Stimulation. Dr. Mari is board certified in American Board Of Psychiatry And Neurology. Dr. Mari is currently accepting new patients.

Expertise in
8
conditions
Expertise in
8
conditions
Referral may be required

Cleveland Clinic Nevada

888 W Bonneville Ave, 
Las Vegas, NV 
 (0.1 miles away)
702-483-6000
Languages Spoken:
English

Jeffrey Cummings is a Neurologist practicing medicine in Las Vegas, Nevada. Dr. Cummings is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Developmental Dysphasia Familial, and Corticobasal Degeneration.

Expertise in
63
conditions
Expertise in
63
conditions
Referral may be required

Cleveland Clinic Nevada

888 W Bonneville Ave, 
Las Vegas, NV 
 (0.1 miles away)
702-483-6000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Odinachi Oguh is a Neurologist practicing medicine in Las Vegas, Nevada. Dr. Oguh is highly rated in 63 conditions, according to our data. Her clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, and Focal Dystonia. Dr. Oguh is board certified in American Board Of Psychiatry And Neurology and American Board Of Psychiatry And Neurology, 2012.

Frequently Asked Questions about Dr. Charles B. Bernick

How do I make an appointment with Dr. Charles B. Bernick?

You can book an appointment with Dr. Charles B. Bernick by calling their office at 702-483-6000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Charles B. Bernick a top-rated expert for Alzheimer's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Charles B. Bernick is classified as an Elite expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Charles B. Bernick specialize in?

While Dr. Charles B. Bernick is a Neurology, they have specific expertise in Alzheimer's Disease, Dementia, and Memory Loss. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Charles B. Bernick participate in research or clinical trials?

Yes. Dr. Charles B. Bernick has published 98 articles and abstracts on conditions like Alzheimer's Disease. You can view a list of Dr. Charles B. Bernick's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Charles B. Bernick accept my insurance?

Dr. Charles B. Bernick accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 702-483-6000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bernick's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 52 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile